Stocks and Investing Stocks and Investing
Wed, February 22, 2023

Ed Arce Maintained (AKBA) at Hold and Held Target at $1.25 on, Feb 22nd, 2023


Published on 2024-10-28 01:47:19 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Hold and Held Target at $1.25 on, Feb 22nd, 2023.

Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com